Centro de Ciências da Saúde, Universidade Federal de Santa Catarina. R. Delfino Conti S/N Trindade, 88040-370. Florianópolis SC Brasil.
Farmácia Escola, Universidade Federal de Santa Catarina. Florianópolis SC Brasil.
Cien Saude Colet. 2021 Nov;26(11):5509-5522. doi: 10.1590/1413-812320212611.13932021. Epub 2021 Jul 9.
Given the COVID-19 pandemic and the importance of public social protection policies, health issues, including immunizations, have gained prominence. This paper aims to analyze the dynamics of vaccine registration in Brazil and the vaccines made available through the National Immunization Program (PNI in Portuguese), with emphasis on the 2004-2018 vaccination schedule. This descriptive, exploratory, documentary research analyzed vaccine registration procedureswith the Brazilian Health Regulatory Agency (ANVISA, in Portuguese) and the incorporation of vaccine products into the PNI. The study drew on information from the national sanitary registration database, made available by ANVISA; a document analysis of official/normative publications; and data from published literature. The data shows the incorporation of vaccines into the PNI, evidencing that Brazil is a country with industrial potential for vaccine production but that is still focused on the transfer of technologies and in need of public attention and investments for developing new technologies as a way to ensure the sector's independence.
鉴于 COVID-19 大流行和公共社会保护政策的重要性,包括免疫接种在内的健康问题受到了关注。本文旨在分析巴西疫苗注册的动态以及国家免疫规划(PNI)提供的疫苗,重点是 2004-2018 年的疫苗接种计划。这是一项描述性、探索性、文献研究,分析了巴西卫生监管机构(ANVISA)的疫苗注册程序以及疫苗产品纳入 PNI 的情况。该研究利用了 ANVISA 提供的国家卫生登记数据库中的信息;对官方/规范出版物的文件分析;以及已发表文献中的数据。数据显示了疫苗纳入 PNI 的情况,表明巴西是一个具有疫苗生产工业潜力的国家,但仍专注于技术转让,需要公众关注和投资来开发新技术,以确保该行业的独立性。